Accurate Conformation-Dependent Molecular Electrostatic Potentials for High-Throughput In Silico Drug Discovery

被引:98
|
作者
Puranen, J. Santeri [1 ]
Vainio, Mikko J. [1 ]
Johnson, Mark S. [1 ]
机构
[1] Abo Akad Univ, Struct Bioinformat Lab, Dept Biochem & Pharm, FI-20520 Turku, Finland
基金
芬兰科学院;
关键词
partial charges; molecular electrostatic potential; conformation dependent; polarizable; electronegativity equalization; ELECTRONEGATIVITY EQUALIZATION METHOD; DERIVING ATOMIC CHARGES; EFFICIENT GENERATION; AM1-BCC MODEL; HARDNESS; PARAMETERIZATION; VALIDATION; ALGORITHM; DENSITY; SMILES;
D O I
10.1002/jcc.21460
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The atom-centered partial charges-approximation is commonly used in current molecular modeling tools as a computationally inexpensive alternative to quantum mechanics for modeling electrostatics. Even today, the use of partial charges remains useful despite significant advances in improving the efficiency of oh initio methods. Here, we report on new parameters for the EEM and SEKEEM electronegativity equalization-based methods for rapidly determining partial charges that will accurately model the electrostatic potential of flexible molecules. The developed parameters cover most pharmaceutically relevant chemistries, and charges obtained using these parameters reproduce the B3LYP/cc-pVTZ reference electrostatic potential of a set of FDA-approved drug molecules at best to an average accuracy of 13 +/- 4 kJ mol(-1); thus, equipped with these parameters electronegativity equalization-based methods rival the current best non-quantum mechanical methods, such as AM1-BCC, in accuracy, yet incur a lower computational cost. Software implementations of EEM and SEKEEM, including the developed parameters, are included in the conformer-generation tool BALLOON, available free of charge at http://web.abo.fi/fak/mnf/bkf/research/johnson/software.php. (C) 2009 Wiley Periodicals, Inc. J Comput Chem 31: 1722-1732, 2010
引用
收藏
页码:1722 / 1732
页数:11
相关论文
共 50 条
  • [1] High-throughput and in silico screenings in drug discovery
    Phatak, Sharangdhar S.
    Stephan, Clifford C.
    Cavasotto, Claudio N.
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (09) : 947 - 959
  • [2] Recent In Silico Research in High-Throughput Drug Discovery and Molecular Biochemistry
    Zhang, Jian
    Chai, Haiting
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (02) : 103 - 104
  • [3] High-throughput kinetics in drug discovery
    Pinto, Maria Filipa
    Sirina, Julija
    Holliday, Nicholas D.
    Mcwhirter, Claire L.
    SLAS DISCOVERY, 2024, 29 (05)
  • [4] High-throughput screening for drug discovery
    Broach, JR
    Thorner, J
    NATURE, 1996, 384 (6604) : 14 - 16
  • [5] Acceleration of high-throughput molecular docking for novel drug discovery on supercomputers
    Ellingson, Sally R.
    Smith, Jeremy C.
    Baudry, Jerome
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [6] High-throughput molecular dynamics: the powerful new tool for drug discovery
    Harvey, Matthew J.
    De Fabritiis, Gianni
    DRUG DISCOVERY TODAY, 2012, 17 (19-20) : 1059 - 1062
  • [7] High-throughput crystallography to enhance drug discovery
    Sharff, A
    Jhoti, H
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (03) : 340 - 345
  • [8] A High-Throughput Screen for Antibiotic Drug Discovery
    Scanlon, Thomas C.
    Dostal, Sarah M.
    Griswold, Karl E.
    BIOTECHNOLOGY AND BIOENGINEERING, 2014, 111 (02) : 232 - 243
  • [9] High-Throughput Flow Cytometry in Drug Discovery
    Ding, Mei
    Edwards, Bruce S.
    SLAS DISCOVERY, 2018, 23 (07) : 599 - 602
  • [10] High-throughput flow cytometry for drug discovery
    Edwards, Bruce S.
    Young, Susan M.
    Saunders, Matthew J.
    Bologa, Cristian
    Oprea, Tudor I.
    Ye, Richard D.
    Prossnitz, Eric R.
    Graves, Steven W.
    Sklar, Larry A.
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (05) : 685 - 696